Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 06/20 16:30 | businesswire.com |
3 Penny Stocks to Buy if You Want to Spend Less and Earn More | 06/11 10:00 | investorplace.com |
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up | 06/10 13:01 | zacks.com |
Is Geron Stock a Buy Following Its First New Drug Approval? | 06/08 06:37 | fool.com |
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers | 06/07 16:10 | investopedia.com |
Geron Corporation: FDA Approval Fuels Stock Price Surge | 06/07 12:57 | marketbeat.com |
Why Is Geron (GERN) Stock Up 18% Today? | 06/07 11:02 | investorplace.com |
Geron shares surge after U.S. FDA approves blood disorder drug | 06/07 06:04 | reuters.com |
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia | 06/06 21:58 | businesswire.com |
Geron Corporation: A High-Risk Deal With A Good Chance Of Success | 05/23 17:49 | seekingalpha.com |